Mood Disorders News

Biomind Labs Inc. announced the completion of dose administration to 30 healthy participants in the phase 2 trial of its novel inhaled formulation, BMND01, to address treatment-resistant depression.

HHS has released its “Roadmap for Behavioral Health Integration,” which details policy solutions to help integrate mental health and substance use care into large health care systems.

Following the COVID-19 pandemic, the need for mental health care among all age groups is significantly prevalent, while the need for emergency psychiatrists continues to play a role in other aspects of the field.

LAS VEGAS — Lesser-known cannabinoids are showing potential for treating neurological disease, inflammation, pain, cancer and infection, according to dermatologist Jeanette Jacknin, MD.

Gate Neurosciences is developing a new portfolio of next-generation therapeutics to treat synaptic dysfunction in patients with central nervous system disorders, the company announced in a press release.

A majority of adults in the United States agreed on the importance of schools playing a key role in advocating for mental health, according to results of a recent survey from the American Psychiatric Association.

According to a recent poll, overall customer satisfaction with Medicare Advantage plans has increased, yet a majority of plan members say they do not have enough coverage for mental health and substance use disorder services.

The American Psychiatric Association has issued a report detailing a strategy for addressing the crisis of psychiatric bed availability and need.

The American Psychiatric Association Foundation has announced a multiyear grant for $20,000 to U.S.-based nonprofit Languages of Care for its Ukraine Disaster Relief Fund.

Environmental factors play a greater role in the genesis of psychotic experiences than genetic factors among adolescents, according to a study published in JAMA Psychiatry.